Massimo Di Nicola

Summary

Affiliation: Istituto Nazionale Tumori
Country: Italy

Publications

  1. ncbi Human dendritic cells: natural adjuvants in antitumor immunotherapy
    M Di Nicola
    Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy
    Cytokines Cell Mol Ther 4:265-73. 1998
  2. ncbi Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes
    M Di Nicola
    Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy
    Hum Gene Ther 10:1875-84. 1999
  3. ncbi Dendritic cells: specialized antigen presenting cells
    M Di Nicola
    C Gandini Bone Marrow Transplantation Unit, Division of Medical Oncology, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy
    Haematologica 85:202-7. 2000
  4. ncbi Large-scale feasibility of gene transduction into human CD34+ cell-derived dendritic cells by adenoviral/polycation complex
    M Di Nicola
    Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy
    Br J Haematol 111:344-50. 2000
  5. ncbi Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
    Massimo Di Nicola
    Cristina Gandini Bone Marrow Transplantation Unit, Istituto Nazionale Tumori, Milano, Italy
    Blood 99:3838-43. 2002
  6. ncbi Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial
    Massimo Di Nicola
    Cristina Gandini Bone Marrow Transplantation Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan I-20133, Italy
    Hum Gene Ther 14:1347-60. 2003
  7. ncbi Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection
    Massimo Di Nicola
    C Gandini Bone Marrow Transplantation Unit, Department of Medical Oncology, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy
    Haematologica 88:1396-404. 2003
  8. ncbi High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults
    Massimo Di Nicola
    Cristina Gandini Bone Marrow Transplantation Unit, Istituto Nazionale Tumori, Milan, Italy
    Br J Haematol 126:815-20. 2004

Detail Information

Publications8

  1. ncbi Human dendritic cells: natural adjuvants in antitumor immunotherapy
    M Di Nicola
    Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy
    Cytokines Cell Mol Ther 4:265-73. 1998
    ....
  2. ncbi Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes
    M Di Nicola
    Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy
    Hum Gene Ther 10:1875-84. 1999
    ..In conclusion, human T lymphocytes can be efficiently transduced, under clinically applicable conditions, by adenovirus-LipofectAMINE complex after 7 days of culture with IL-2 and IL-12 or IL-7...
  3. ncbi Dendritic cells: specialized antigen presenting cells
    M Di Nicola
    C Gandini Bone Marrow Transplantation Unit, Division of Medical Oncology, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milano, Italy
    Haematologica 85:202-7. 2000
    ..The chairmen have prepared this report for the readers of Haematologica...
  4. ncbi Large-scale feasibility of gene transduction into human CD34+ cell-derived dendritic cells by adenoviral/polycation complex
    M Di Nicola
    Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy
    Br J Haematol 111:344-50. 2000
    ..Cryopreservation of transduced DCs did not damage their viability or APC functions, thus making it possible to plan multiple injections of engineered DC-based vaccines...
  5. ncbi Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
    Massimo Di Nicola
    Cristina Gandini Bone Marrow Transplantation Unit, Istituto Nazionale Tumori, Milano, Italy
    Blood 99:3838-43. 2002
    ....
  6. ncbi Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial
    Massimo Di Nicola
    Cristina Gandini Bone Marrow Transplantation Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan I-20133, Italy
    Hum Gene Ther 14:1347-60. 2003
  7. ncbi Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection
    Massimo Di Nicola
    C Gandini Bone Marrow Transplantation Unit, Department of Medical Oncology, Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy
    Haematologica 88:1396-404. 2003
    ..However, the clinical use of killed tumor cells as a source of antigens will require an optimal methodology to induce effective tumor cell apoptosis...
  8. ncbi High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults
    Massimo Di Nicola
    Cristina Gandini Bone Marrow Transplantation Unit, Istituto Nazionale Tumori, Milan, Italy
    Br J Haematol 126:815-20. 2004
    ..Confirmation of these excellent efficacy and feasibility results by larger, multicentre and prospective studies is warranted...